Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rachele Berria, MD, et al. - Thiazolidinediones have gained widespread use for the treatment of type 2 diabetes mellitus and other insulin resistance states, including polycystic ovary syndrome (PCOS). In thiazolidinedione-treated patients a small reduction in hemoglobin and hematocrit levels often is observed, and this generally has been attributed to fluid retention


Previous Article Next Article

Today in Adverse Drug Reactions...keeping you current

Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Pediatrics, 07/02/09

Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients
Néphrologie & Thérapeutique , 06/09/09

Narrative Review: Statin-Related Myopathy
Annals of Internal Medicine, 06/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address